PURPOSE: The use of dendrimers for biomedical applications has emerged with promising results. 2G-NN16 is a carbosilane dendrimer with sixteen positive charges per molecule tested to be capable to bind and release antisense oligonucleotides (ODNs) and small interference RNA (siRNA) in vitro. In spite of low cytotoxicity observed for these dendrimers, little is known about cellular changes they produce in cells in general and in immune cells in particular. MATERIALS AND METHODS: Genomic technologies allow us to identify global gene expression profile changes in macrophages exposed to a non-toxic concentration (5 microM) of 2G-NN16, alone or complexed with a random siRNA (dendriplex). Results were confirmed by quantitative real-time RT-PCR. RESULTS: Exposing macrophages to this dendrimer or dendriplex causes multiple gene expression changes, but no specific action of random siRNA was detected. Pathway analysis of differentially expressed genes shows the altered functions to be immune response, proliferation and transcription regulation. Interleukin 17F (IL17F) was the most regulated gene. CONCLUSIONS: Global gene expression profiles are a highly sensitive method to measure the toxicity degree of a gene delivery vehicle. The strong repression of IL17F, IL23R and IL23A, all of which are involved in autoimmune disease, by this particular dendrimer suggests a potential pharmacological application.
PURPOSE: The use of dendrimers for biomedical applications has emerged with promising results. 2G-NN16 is a carbosilane dendrimer with sixteen positive charges per molecule tested to be capable to bind and release antisense oligonucleotides (ODNs) and small interference RNA (siRNA) in vitro. In spite of low cytotoxicity observed for these dendrimers, little is known about cellular changes they produce in cells in general and in immune cells in particular. MATERIALS AND METHODS: Genomic technologies allow us to identify global gene expression profile changes in macrophages exposed to a non-toxic concentration (5 microM) of 2G-NN16, alone or complexed with a random siRNA (dendriplex). Results were confirmed by quantitative real-time RT-PCR. RESULTS: Exposing macrophages to this dendrimer or dendriplex causes multiple gene expression changes, but no specific action of random siRNA was detected. Pathway analysis of differentially expressed genes shows the altered functions to be immune response, proliferation and transcription regulation. Interleukin 17F (IL17F) was the most regulated gene. CONCLUSIONS: Global gene expression profiles are a highly sensitive method to measure the toxicity degree of a gene delivery vehicle. The strong repression of IL17F, IL23R and IL23A, all of which are involved in autoimmune disease, by this particular dendrimer suggests a potential pharmacological application.
Authors: S Kotake; N Udagawa; N Takahashi; K Matsuzaki; K Itoh; S Ishiyama; S Saito; K Inoue; N Kamatani; M T Gillespie; T J Martin; T Suda Journal: J Clin Invest Date: 1999-05 Impact factor: 14.808
Authors: Frank Alexis; June-Wha Rhee; Jerome P Richie; Aleksandar F Radovic-Moreno; Robert Langer; Omid C Farokhzad Journal: Urol Oncol Date: 2008 Jan-Feb Impact factor: 3.498
Authors: S G Hymowitz; E H Filvaroff; J P Yin; J Lee; L Cai; P Risser; M Maruoka; W Mao; J Foster; R F Kelley; G Pan; A L Gurney; A M de Vos; M A Starovasnik Journal: EMBO J Date: 2001-10-01 Impact factor: 11.598
Authors: Jesus F Bermejo; Paula Ortega; Louis Chonco; Ramon Eritja; Rafael Samaniego; Matthias Müllner; Ernesto de Jesus; F Javier de la Mata; Juan Carlos Flores; Rafael Gomez; Angeles Muñoz-Fernandez Journal: Chemistry Date: 2007 Impact factor: 5.236
Authors: Eva V Acosta-Rodriguez; Laura Rivino; Jens Geginat; David Jarrossay; Marco Gattorno; Antonio Lanzavecchia; Federica Sallusto; Giorgio Napolitani Journal: Nat Immunol Date: 2007-05-07 Impact factor: 25.606
Authors: Luca Vannucci; Anna Fiserová; Kashinath Sadalapure; Thisbe K Lindhorst; Marketa Kuldová; Pavel Rossmann; Ondrej Horváth; Vladimir Kren; Pavel Krist; Karel Bezouska; Martina Luptovcová; Franco Mosca; Miloslav Pospísil Journal: Int J Oncol Date: 2003-08 Impact factor: 5.650
Authors: Stephen D Hurst; Tony Muchamuel; Daniel M Gorman; Jonathan M Gilbert; Theresa Clifford; Sylvia Kwan; Satish Menon; Brian Seymour; Craig Jackson; Ted T Kung; Joan K Brieland; Sandra M Zurawski; Richard W Chapman; Gerard Zurawski; Robert L Coffman Journal: J Immunol Date: 2002-07-01 Impact factor: 5.422
Authors: Olivia M Merkel; Meredith A Mintzer; Damiano Librizzi; Olga Samsonova; Tanja Dicke; Brian Sproat; Holger Garn; Peter J Barth; Eric E Simanek; Thomas Kissel Journal: Mol Pharm Date: 2010-08-02 Impact factor: 4.939
Authors: Linda B Jensen; Joscha Griger; Broes Naeye; Amir K Varkouhi; Koen Raemdonck; Raymond Schiffelers; Twan Lammers; Gert Storm; Stefaan C de Smedt; Brian S Sproat; Hanne M Nielsen; Camilla Foged Journal: Pharm Res Date: 2011-10-05 Impact factor: 4.200
Authors: Caterina Fede; Caterina Millino; Beniamina Pacchioni; Barbara Celegato; Chiara Compagnin; Paolo Martini; Francesco Selvestrel; Fabrizio Mancin; Lucia Celotti; Gerolamo Lanfranchi; Maddalena Mognato; Stefano Cagnin Journal: Int J Environ Res Public Health Date: 2014-08-28 Impact factor: 3.390